Anti-Obesity Drugs: A Review about Their Effects and Safety - Test2 - elhamkhani - TriplyDB

Anti-Obesity Drugs: A Review about Their Effects and Safety

Anti-Obesity Drugs: A Review about Their Effects and Safety

http://www.wikidata.org/entity/Q24630947

about

Weight loss intervention through lifestyle modification or pharmacotherapy for obstructive sleep apnoea in adults Weight loss intervention through lifestyle modification or pharmacotherapy for obstructive sleep apnoea in adults Hunger and Satiety Mechanisms and Their Potential Exploitation in the Regulation of Food Intake Medicinal Plants and Their Inhibitory Activities against Pancreatic Lipase: A Review Therapeutic phytogenic compounds for obesity and diabetes IL-17 Axis Driven Inflammation in Non-Alcoholic Fatty Liver Disease Progression Marine Algae as a Potential Source for Anti-Obesity Agents Effects of Saponins on Lipid Metabolism: A Review of Potential Health Benefits in the Treatment of Obesity Preclinical models for obesity research Operon for biosynthesis of lipstatin, the Beta-lactone inhibitor of human pancreatic lipase The natural product magnolol as a lead structure for the development of potent cannabinoid receptor agonists New and unconventional treatments for obstructive sleep apnea.Macrocytic anemia and thrombocytopenia induced by orlistat.Cardiovascular effects of phentermine and topiramate: a new drug combination for the treatment of obesity Fenugreek seed extract inhibit fat accumulation and ameliorates dyslipidemia in high fat diet-induced obese rats.Effects of anti-obesity drugs, phentermine and mahuang, on the behavioral patterns in Sprague-Dawley rat model.Carboxylesterase-2 is a highly sensitive target of the antiobesity agent orlistat with profound implications in the activation of anticancer prodrugs.Devil's Claw to suppress appetite--ghrelin receptor modulation potential of a Harpagophytum procumbens root extract Access to weight reduction interventions for overweight and obese patients in UK primary care: population-based cohort study Biting off more than we can chew: is BMI the correct standard for bariatric surgery eligibility?The effectiveness of interventions to treat obesity in survivors of childhood brain tumors: a systematic review protocol.Post-marketing withdrawal of anti-obesity medicinal products because of adverse drug reactions: a systematic review Recent Advances in Effect-directed Enzyme Assays based on Thin-layer Chromatography.Obesity pharmacotherapy: current status Diabetes: have we got it all wrong? Insulin hypersecretion and food additives: cause of obesity and diabetes?Glucagon increases energy expenditure independently of brown adipose tissue activation in humans.One-year effectiveness of a 3-week balneotherapy program for the treatment of overweight or obesity Intestinal removal of free fatty acids from hosts by Lactobacilli for the treatment of obesity.Efficacy and tolerability of an herbal formulation for weight management.Efficacy and Safety of Taeeumjowi-tang in Obese Korean Adults: A Double-Blind, Randomized, and Placebo-Controlled Pilot Trial.Preclinical safety evaluation of low molecular weight galactomannans based standardized fenugreek seeds extract.Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity.Treatment of obesity with the resveratrol-enriched rice DJ-526 The Obesity-Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients.Peptide Fraction pOh2 Exerts Antiadipogenic Activity through Inhibition of C/EBP-α and PPAR-γ Expression in 3T3-L1 Adipocytes.Inhibitors of fatty acid synthesis in prokaryotes and eukaryotes as anti-infective, anticancer and anti-obesity drugs.Outcomes of laparoscopic Roux-en-Y gastric bypass versus laparoscopic adjustable gastric banding in adolescents.Treating the obese diabetic.The unrelenting fall of the pharmacological treatment of obesity.Peripheral targets in obesity treatment: a comprehensive update.

P2860

Q24202645-6D62A6C3-BE21-469F-BE78-1FC51C1AC718 Q26471370-FDDDF34A-E559-45BD-ACD5-867E2CCB223D Q26772113-A007990A-27FB-44ED-8BCE-4193800656C8 Q26774088-3E5DBD00-7656-4C89-BF87-970635078B4C Q27004043-B9FDEBDC-052C-4396-A1C3-0C1BBD461EF5 Q27025620-5F89671A-C538-4436-8E69-227697AB6DD1 Q28070329-58DF135F-7A9C-42A2-8956-5C33C78A6658 Q28072050-20F485A3-813E-48E4-878F-3E2D24B8ACA9 Q28078164-9A1524D1-F33B-4FD3-821A-D7A60C056CFD Q28248341-D2ABE24C-1332-489A-A6B5-973CBB5975DE Q28534752-3F26A7D9-92AF-44B6-B487-BE5136A617FD Q30526453-2A1148E8-A144-4F39-ACC0-21A37F3CD34B Q33414543-B4C6C783-1AAA-42F0-9C54-20A306EF340D Q33572190-85CFB11B-B945-45C4-9AAC-C55838C46B3C Q33609025-C15CE533-F1FD-49FE-B390-3612100842A2 Q33838889-4BFC45DD-9E8C-438A-802D-9F506CD24B69 Q33916086-90B23458-23D6-407B-A87B-344BF2813456 Q33961384-A52AF2B2-86E1-4180-AE2A-B6EB97FB6FC9 Q35046839-6EF33C91-0150-4C46-9B0A-B8C3A94ED9F9 Q35966943-A603100A-C0E9-49F6-9E11-136FCD15F3CC Q36052329-C980CD5F-3A6F-4072-B048-BF7585FB3949 Q36206061-B80A7CB4-0263-4F81-A2C1-9D5325277018 Q36266184-6C845719-A955-46F8-B0D3-509194DA2F31 Q36341202-E53A8CE5-895B-44EE-9C6B-A0C7A1420F62 Q36426723-8A198C48-54F6-4146-B1B5-84213D543AF5 Q36457015-6DA984F5-FB71-4365-8C76-C1D96EDFF1DF Q36529706-2C70C107-31D9-4B9C-BE70-AF8C5540E055 Q36694416-2CED9CC4-CD9E-41B6-ACB8-94372E9F2524 Q36933466-6FDE1235-E525-4903-A1B6-A58B0EAEA804 Q37162854-AF34ECFB-5043-476F-9C74-C1BA9DFF4694 Q37373724-A6371BAA-B577-43D4-9DEE-A453B529B2C3 Q37501257-1338701A-5936-444A-81EC-9CD89D233C6C Q37517007-38A9EBB2-557C-448B-ACBF-968D566D22F7 Q37637480-E62FE1EC-8DB0-44D9-95DA-A1538BC90496 Q37739236-35271907-AA9B-4860-8072-9332E3E4FF9E Q38019608-355671CE-7DDA-4643-8BA7-44953572F5E9 Q38038117-7D6E6857-D280-414E-A74B-44CF481AAF8B Q38087696-9AE7F714-0F19-4BDA-93E2-4B3B7B5B7053 Q38107134-CACAA057-ACC6-4BD1-B3A8-3D3B4AB04E84 Q38194649-6A1778B8-1AA2-4855-A715-96211585CF6B

P2860

Anti-Obesity Drugs: A Review about Their Effects and Safety

http://www.wikidata.org/entity/Q24630947

description

2012 nî lūn-bûn

@nan

2012 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Anti-Obesity Drugs: A Review about Their Effects and Safety

@ast

Anti-Obesity Drugs: A Review about Their Effects and Safety

@en

Anti-Obesity Drugs: A Review about Their Effects and Safety

@nl

type

label

Anti-Obesity Drugs: A Review about Their Effects and Safety

@ast

Anti-Obesity Drugs: A Review about Their Effects and Safety

@en

Anti-Obesity Drugs: A Review about Their Effects and Safety

@nl

prefLabel

Anti-Obesity Drugs: A Review about Their Effects and Safety

@ast

Anti-Obesity Drugs: A Review about Their Effects and Safety

@en

Anti-Obesity Drugs: A Review about Their Effects and Safety

@nl

P1433

Q24630947-BF32D43A-642E-429A-A290-BBA94D81C979

P1476

Q24630947-62F10BF4-6675-4F70-98C2-DAAAAFB9744C

P2093

Q24630947-75848CFD-FCF3-4A11-99F9-C7C9ED397A7D

Q24630947-A072EF1B-A38D-4AD3-8A4C-95C4F95C05BE

P2860

Q24630947-02011051-D747-4DFD-8510-AF573939358F

Q24630947-0845C096-A24D-4A95-AC27-9B125135E36E

Q24630947-09DA31E8-24D9-4646-B706-C579543C8270

Q24630947-10F7994E-C15A-478D-A176-3B0CAAB8F36D

Q24630947-15355F23-54B0-4297-8364-11AC384D8428

Q24630947-176D43D9-8338-4101-B0E7-96E57B145410

Q24630947-20A24B7A-03D3-4AE9-BEE2-3D8A7D4C124E

Q24630947-229EAE4F-D3ED-47D2-8D14-202986C18D8D

Q24630947-2570F855-FBC0-460C-881B-00576D51964C

Q24630947-2D297B17-A656-43CD-B9A5-8C185CED06F8

P304

Q24630947-1DA85D68-B747-4716-99D1-ED962A4CD93C

P31

Q24630947-E1CC48E2-8642-4C93-B779-BC0EA88784F4

P3181

Q24630947-56448713-E882-4421-A546-1545F5D91C6F

P356

Q24630947-915A91F4-A417-4FAA-BD87-BB5EE6820461

P407

Q24630947-7EAC4423-A35B-4807-AC3A-D642AEC9D138

P433

Q24630947-02843A0F-3EC5-4D6F-94F8-60735BDD4162

P478

Q24630947-D8D6B1F5-6400-4F3E-AF0E-B3F382F2AE96

P577

Q24630947-0EE8FE55-C4DF-4FE5-84B5-1E39EF9FB13A

P5875

Q24630947-1D7D393F-19FE-41FE-B9B0-963D1CA98572

P698

Q24630947-24931013-D488-4BA0-B6E2-2D012BF6E1D7

P921

Q24630947-860DDD5F-5D15-45C9-8B3B-C5AEBF078CF1

P932

Q24630947-A45C3C3E-A67C-4EC4-94C9-D536D8973930

P3181

P356

DMJ.2012.36.1.13

P1433

Diabetes & metabolism journal

P1476

Anti-Obesity Drugs: A Review about Their Effects and Safety

@en

P2093

Cheol-Young Park

http://www.w3.org/2001/XMLSchema#string

Jun Goo Kang

http://www.w3.org/2001/XMLSchema#string

P2860

Long term pharmacotherapy for obesity and overweight: updated meta-analysis.

Long-term pharmacotherapy for obesity and overweight

Valvular heart disease associated with fenfluramine-phentermine

Weight loss produced by tesofensine in patients with Parkinson's or Alzheimer's disease

Clinical Guidelines on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults--The Evidence Report. National Institutes of Health

Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial

Overweight, obesity, and health risk.

XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients.

A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study.

A clinical trial assessing the safety and efficacy of taranabant, a CB1R inverse agonist, in obese and overweight patients: a high-dose study.

P304

13-25

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

791056

http://www.w3.org/2001/XMLSchema#string

P356

10.4093/DMJ.2012.36.1.13

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P577

2012-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221860200

http://www.w3.org/2001/XMLSchema#string

P698

22363917

http://www.w3.org/2001/XMLSchema#string

P921

P932

3283822

http://www.w3.org/2001/XMLSchema#string